On Friday, Shares of Onconova Therapeutics, Inc. (NASDAQ:ONTX), surged 22.73% to $2.43.
Onconova Therapeutics declared the appointment of James J. Marino J.D., MBA, to its Board of Directors.
James J. Marino was a Partner at the global law firm of Dechert LLP for 28 years where he served as Managing Partner of the Princeton Office. During this period, he advised numerous leading life science companies in connection with financings, acquisitions and planned alliances. Mr. Marino served as the outside counsel for Onconova from its inception through and counting its initial public offering. Formerly, he served on the Board of Directors of Pharmacopeia Drug Discovery, Inc. from 2000-2006 and has worked in advisory capacities and on the boards of multiple non-profit organizations, counting Robert Wood Johnson University Hospital. Mr. Marino was one of the co-founders of BioNJ, a trade association of biotech companies, which he has represented since 1994. He presently serves on the Board of Trustees of Wake Forest University and Wake Forest Baptist Medical Center. Mr. Marino received his B.A., J.D. and MBA from Rutgers University. Mr. Marino will join the Company’s Audit and Compensation Committees.
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule drug candidates to treat cancer.
Shares of American Airlines Group Inc. (NASDAQ:AAL), inclined 0.49% to $42.88, during its last trading session.
American Airlines Group stated July 2015 and year-to-date traffic results.
American Airlines Group’s total revenue passenger miles (RPMs) for the month were a record 21.8 billion, up 4.8 percent as compared to July 2014. Total capacity was a record 24.9 billion accessible seat miles (ASMs), up 2.2 percent as compared to July 2014. Total passenger load factor was 87.3 percent, up 2.2 percentage points as compared to July 2014.
The Company continues to expect its third quarter 2015 merged passenger revenue per accessible seat mile (PRASM) to be down about six to eight percent year-over-year. In addition, the Company continues to expect its third quarter pretax margin not taking into account special items to be between 16 and 18 percent.
American Airlines Group Inc., through its auxiliaries, operates in the airline industry. As of December 31, 2014, the company operated 983 mainline jets, in addition to 566 regional aircrafts through regional airline auxiliaries and third-party regional carriers. It serves 339 destinations in 54 countries.
Finally, T. Rowe Price Group, Inc. (NASDAQ:TROW), ended its last trade with 0.32% gain, and closed at $76.07.
T. Rowe Price Group, declared that its Board of Directors has declared a quarterly dividend of $0.52 per share payable September 29, 2015 to stockholders of record as of the close of business on September 15, 2015.
T. Rowe Price Group, Inc. is a publicly owned asset administration holding company. The firm provides its services to individuals, institutional investors, retirement plans, financial intermediaries, and institutions. Through its auxiliaries, it launches and manages equity and fixed income mutual funds.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
